Our results demonstrated that fisetin inhibits melanoma cell invasion by targeting the MAPK and NFκB signaling pathways in metastatic melanoma cells and in three-dimensional reconstituted human melanoma skin equivalents. Here, NFKB1 is linked to metastatic melanoma.